Who makes human biphasic insulin, reference?

human biphasic insulin, reference is developed by Julphar Gulf Pharmaceutical Industries.

What development phase is human biphasic insulin, reference in?

human biphasic insulin, reference is in Phase 1.

Last reviewed 2026-04-19 · How we verify

human biphasic insulin, reference

Julphar Gulf Pharmaceutical Industries · Phase 1 active Small molecule

At a glance

Generic name	human biphasic insulin, reference
Also known as	Huminsulin® Profil III
Sponsor	Julphar Gulf Pharmaceutical Industries
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

human biphasic insulin, reference CI brief — competitive landscape report
human biphasic insulin, reference updates RSS · CI watch RSS
Julphar Gulf Pharmaceutical Industries portfolio CI